Atlas FDA

COBAS AMPLIPREP/COBAS TAQMAN CMV TEST

FDA premarket approval P110037/S001 · decided 2012-09-05

Approval details

PMA number
P110037
Supplement
S001
Supplement type
Real-Time Process
Supplement reason
Change Design/Components/Specifications/Material
Trade name
COBAS AMPLIPREP/COBAS TAQMAN CMV TEST
Generic name
Cytomegalovirus (cmv) dna quantitative assay
Applicant
Roche Molecular Systems, Inc.
Date received
2012-08-07
Decision date
2012-09-05
Days to decision
29 days
Decision code
APPR
Product code
PAB
Advisory committee
Microbiology
Expedited review
No
Location
Pleasanton, CA
Statement
APPROVAL FOR A CHANGE TO THE TEST DEFINITION FILE (TDF). THE DEVICE, AS MODIFIED, WILL BE MARKETED UNDER THE TRADE NAME COBAS AMPLIPREP/COBAS TAQMAN CMV TEST AND IS INDICATED FOR: COBAS AMPLIPREP/COBAS TAQMAN CMV TEST THE COBAS AMPLIPREP/ COBAS TAQMAN CMV TEST IS AN IN VITRO NUCLEIC ACID AMPLIFICATION TEST FOR THE QUANTITATIVE MEASUREMENT OF CYTOMEGALOVIRUS (CMV) DNA INHUMAN EDTA PLASMA USING THE COBAS AMPLIPRCP INSTRUMENT FOR AUTOMATED SPECIMEN PROCESSING AND THE COBAS TAQMAN ANALYZER OR THE CO

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
cobas® BV/CV (K260021)Roche Molecular Systems, Inc.2026-07-16
cobas CT/NG for use on the cobas 5800/6800/8800 systems; cobas TV/MG for use on the cobas 5800/6800/8800 systems (K260917)Roche Molecular Systems, Inc.2026-07-08
cobas liat CT/NG/MG nucleic acid test (K253759)Roche Molecular Systems, Inc.2026-05-15
cobas liat CT/NG nucleic acid test (K253756)Roche Molecular Systems, Inc.2026-05-15
cobas liat Bordetella panel nucleic acid test (K243753)Roche Molecular Systems, Inc.2025-11-20
cobas CMV (K252481)Roche Molecular Systems, Inc.2025-11-03
cobas HCV (K252484)Roche Molecular Systems, Inc.2025-11-03
cobas Respiratory 4-flex for use on the cobas 5800/6800/8800 Systems (K243455)Roche Molecular Systems, Inc.2025-07-31